These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7087954)

  • 21. Long-term effect of intravenous immunoglobulin on anti-MuSK antibody-positive myasthenia gravis.
    Shibata-Hamaguchi A; Samuraki M; Furui E; Iwasa K; Yoshikawa H; Hayashi S; Yamada M
    Acta Neurol Scand; 2007 Dec; 116(6):406-8. PubMed ID: 17986100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular production of antibodies related to the acetylcholine receptor in myasthenia gravis: correlation with clinical stage.
    Lefvert AK; Holm G; Sundén H; Pirskanen R
    Scand J Immunol; 1987 Mar; 25(3):265-73. PubMed ID: 2436288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies.
    Sundewall AC; Lefvert AK; Norberg R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):184-95. PubMed ID: 3665199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myasthenia and neuroborreliosis with excessively high acetylcholine-receptor antibodies.
    Finsterer J
    Scand J Infect Dis; 2007; 39(2):187-90. PubMed ID: 17366045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis and pathophysiology of myasthenia gravis--role of anti-acetylcholine receptor antibody (author's transl)].
    Nishitani H; Noguchi S; Ohta K; Matsubara S
    No To Shinkei; 1980 Sep; 32(9):879-90. PubMed ID: 7437163
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives for monoclonal antibodies in receptor research.
    Yavin E
    Horiz Biochem Biophys; 1982; 6():67-81. PubMed ID: 6194099
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pathogenesis and pathophysiology of myasthenia gravis--the role of thymus in myasthenia gravis (author's transl)].
    Ohshima F
    No To Shinkei; 1980 Sep; 32(9):909-19. PubMed ID: 7437164
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoimmunity in ocular and generalised myasthenia gravis.
    Garlepp MJ; Dawkins RL; Christiansen FT; Lawton J; Luciani G; McLeod J; Bradley J; Genkins G; Teng CS
    J Neuroimmunol; 1981 Sep; 1(3):325-32. PubMed ID: 7334085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis.
    Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A
    Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of anti-acetylcholine receptor antibodies in Praomys (Mastomys) natalensis.
    Vincent A; Solleveld HA
    Clin Exp Immunol; 1981 Jan; 43(1):94-8. PubMed ID: 7249398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The human acetylcholine receptor antibody: studies of kinetic and biochemical properties and the reaction with anti-idiotypic antibodies.
    Lefvert AK
    Ann N Y Acad Sci; 1981; 377():125-42. PubMed ID: 6951468
    [No Abstract]   [Full Text] [Related]  

  • 37. Experimental myasthenia gravis is inhibited by receptor-antireceptor complexes.
    Barkas T; Simpson JA
    J Clin Lab Immunol; 1982 Apr; 7(3):223-7. PubMed ID: 7097749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of human anti-acetylcholine receptor monoclonal autoantibodies from the peripheral blood of a myasthenia gravis patient using combinatorial libraries.
    Rey E; Zeidel M; Rhine C; Tami J; Krolick K; Fischbach M; Sanz I
    Clin Immunol; 2000 Sep; 96(3):269-79. PubMed ID: 10964546
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myasthenia gravis and the anti-idiotype theory of autoimmunity.
    Bradley RJ
    Lancet; 1984 Feb; 1(8373):396. PubMed ID: 6141456
    [No Abstract]   [Full Text] [Related]  

  • 40. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease.
    Toth C; McDonald D; Oger J; Brownell K
    Acta Neurol Scand; 2006 Aug; 114(2):124-32. PubMed ID: 16867036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.